Plasticity of purine release during cerebral ischemia: clinical implications?

被引:48
作者
Pearson, T
Currie, AJ
Etherington, LAV
Gadalla, AE
Damian, K
Llaudet, E
Dale, N
Frenguelli, HG [1 ]
机构
[1] Univ Dundee, Ninewells Hosp & Med Sch, Dept Pharmacol & Neurosci, Dundee DD1 9SY, Scotland
[2] Univ Warwick, Sch Biol Sci, Coventry, W Midlands, England
来源
JOURNAL OF CELLULAR AND MOLECULAR MEDICINE | 2003年 / 7卷 / 04期
关键词
adenosine; inosine; glutamate; hypoxia; ischemia; seizure; epilepsy TBI; purities; purinoceptor; ATP; nucleotides; nucleosides;
D O I
10.1111/j.1582-4934.2003.tb00239.x
中图分类号
Q2 [细胞生物学];
学科分类号
071009 ; 090102 ;
摘要
Adenosine is a powerful modulator of neuronal function in the mammalian central nervous system. During a variety of insults to the brain, adenosine is released in large quantities and exerts a neuroprotective influence largely via the A, receptor, which inhibits glutamate release and neuronal activity. Using novel enzyme-based adenosine sensors, which allow high spatial and temporal resolution recordings of adenosine release in real time, we have investigated the release of adenosine during hypoxia/ischemia in the in vitro hippocampus. Our data reveal that during the early stages of hypoxia adenosine is likely released per se and not as a precursor such as cAMP or an adenine nucleotide. In addition, repeated hypoxia results in reduced production of extracellular adenosine and this may underlie the increased vulnerability of the mammalian brain to repetitive or secondary hypoxia/ischemia.
引用
收藏
页码:362 / 375
页数:14
相关论文
共 100 条
[1]   Aggravated brain damage after hypoxic ischemia in immature adenosine A2A knockout mice [J].
Ådén, U ;
Halldner, L ;
Lagercrantz, H ;
Dalmau, I ;
Ledent, C ;
Fredholm, BB .
STROKE, 2003, 34 (03) :739-744
[2]   The effect of allopurinol on focal cerebral ischaemia:: an experimental study in rabbits [J].
Akdemir, H ;
Asik, Z ;
Pasaoglu, H ;
Karaküçük, I ;
Öktem, IS ;
Koç, RK .
NEUROSURGICAL REVIEW, 2001, 24 (2-3) :131-135
[3]   Adenosine A2A receptor antagonist treatment of Parkinson's disease [J].
Bara-Jimenez, W ;
Sherzai, A ;
Dimitrova, T ;
Favit, A ;
Bibbiani, F ;
Gillespie, M ;
Morris, MJ ;
Mouradian, MM ;
Chase, TN .
NEUROLOGY, 2003, 61 (03) :293-296
[4]   Pathways for α-D-ribose utilization for nucleobase salvage and 5-fluorouracil activation in rat brain [J].
Barsotti, C ;
Ipata, PL .
BIOCHEMICAL PHARMACOLOGY, 2002, 63 (02) :117-122
[5]   Interstitial brain adenosine and xanthine increase during jugular venous oxygen desaturations in humans after traumatic brain injury [J].
Bell, MJ ;
Robertson, CS ;
Kochanek, PM ;
Goodman, JC ;
Gopinath, SP ;
Carcillo, JA ;
Clark, RSB ;
Marion, DW ;
Mi, ZC ;
Jackson, EK .
CRITICAL CARE MEDICINE, 2001, 29 (02) :399-404
[6]   Adenosine receptors and Huntington's disease: implications for pathogenesis and therapeutics [J].
Blum, D ;
Hourez, R ;
Galas, MC ;
Popoli, P ;
Schiffmann, SN .
LANCET NEUROLOGY, 2003, 2 (06) :366-374
[7]   Activity-dependent release of adenosine contributes to short-term depression at CA3-CA1 synapses in rat hippocampus [J].
Brager, DH ;
Thompson, SM .
JOURNAL OF NEUROPHYSIOLOGY, 2003, 89 (01) :22-26
[8]  
Braun N, 1998, J NEUROSCI, V18, P4891
[9]  
Brundege J M, 1997, Adv Pharmacol, V39, P353, DOI 10.1016/S1054-3589(08)60076-9
[10]   The role of cyclic AMP as a precursor of extracellular adenosine in the rat hippocampus [J].
Brundege, JM ;
Diao, LH ;
Proctor, WR ;
Dunwiddie, TV .
NEUROPHARMACOLOGY, 1997, 36 (09) :1201-1210